Regado Biosciences regadobio.com


Public lists: Pharma Startups (4732)

Regado Biosciences, a biopharmaceutical company, engages in the discovery and development of aptamer-based antidote-controlled therapeutics. The Company provides REG1 that is used in patients suffering from acute coronary syndrome that undergo coronary revascularization procedures, which include coronary artery bypass grafting and percutaneous coronary intervention.

Regado Biosciences, a biopharmaceutical company, engages in the discovery and development of aptamer-based antidote-controlled therapeutics. The Company provides REG1 that is used in patients suffering from acute coronary syndrome that undergo corona...Show all

Company (IPO / Went public)

Phone: 908-580-2100

Fax:

120 Mountainview Blvd.

Basking Ridge, 07920
New Jersey, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Regado Biosciences $215.6M Aug 22, 2013
See all 18 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Regado Biosciences Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 11 investors

Competitors

Company Status Description Investors

gera Therapeutics

Canada
AcquiredAegera Therapeutics, located in Montreal, Canada, is a business unit of Pharmascience focused on developing targeted therapeutics to address major unmet medical needs. Aegera focuses on preclinical and early-stage clinical development through integration of "in-house" medicinal chemistry, biochemistry, cell biology, pharmacokinetics and in vivo pharmacology/efficacy. Aegera has two oncology programs in clinical development. Aegera is also dedicated to identifying novel development candidates bas...Show allLogin to see details

Threshold Pharmaceuticals

Redwood City, California, United States
MergedThreshold Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of small molecule therapeutics based on Metabolic Targeting, an approach that offers broad potential to treat most solid tumors and certain other diseases. By selectively targeting tumor and certain other diseased cells, Threshold's pipeline of drug candidates holds promise to be more effective and less toxic to healthy tissues than conventional drugs. Threshold's initial clinical foc...Show allLogin to see details
See all 18 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Nucleic acid modulators of glycoprotein vi Nov 07, 2012 Nov 18, 2014 Patent
Nucleic acid modulators of glycoprotein vi Nov 07, 2012 Nov 18, 2014 Patent
Modulators of coagulation factors Jan 28, 2013 Oct 14, 2014 Patent
Modulators of coagulation factors Apr 12, 2010 Mar 05, 2013 Patent
Nucleic acid modulators of glycoprotein vi Jun 03, 2010 Nov 27, 2012 Patent
See all 9 patents